FBTAX Mutual Fund

FBTAX Mutual Fund (Fidelity Advisor Biotechnology Fund Class A) is managed by Fidelity Investments (US) with $891.2M in net assets. FBTAX expense ratio is 0.96%, holding 98 positions across sectors including Health Care, Financials. Inception date: 2000-12-27.

FBTAX performance shows a YTD return of 21.53%. The 1-year return is 62.66% and the 5-year return is 12.58%. FBTAX dividend yield stands at 0.91%, paid semi-annually.

FBTAX top holdings include Abbvie Inc. (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmaceuticals Inc. (5.0%), Ascendis Pharma A/S (4.5%), Cogent Biosciences Inc (3.8%). Go to all FBTAX holdings, FBTAX sectors, or FBTAX dividends.

FBTAX can be compared against other funds. Use FBTAX overlap to find shared positions, or FBTAX vs another fund for a side-by-side view. FBTAX alternatives are available via the screener, along with tax-loss harvesting opportunities.